ARCA:PJP
Invesco Pharmaceuticals ETF | |
| $ 115.6762 0.7757 ( +0.68%) 03:52 PM EST | |
PE Ratio:
21.07
PB Ratio:
2.98
Volume:
4.78K
Dividend Yield %:
0.92
| |
| Last Holding update 2026-03-30 | 29 Stocks (1 new) |
| Value $402.00 Mil | Turnover 31 % |
Registrant: Invesco Pharmaceuticals ETF
| |
Year: 2026
GuruFocus Rankings
Financial Strength
6 /10
Profitability Rank
7 /10
GF Value Rank
6 /10
Growth Rank
7 /10
Momentum Rank
5 /10
Invesco Pharmaceuticals ETF Geographic Breakdown
Invesco Pharmaceuticals ETF Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Invesco Pharmaceuticals ETF Key Statistics
| Name | Value | ||
|---|---|---|---|
| Day's Open ($) | 114.87 | ||
| Day's Range ($) | 114.87 - 117.0858 | ||
| Day's Volume | 4,780 | ||
| 52-Week Range ($) | 79.47 - 117.0858 | ||
| Beta | 0.476 | ||
| 3-Year Sharpe Ratio | 0.67 | ||
| 3-Year Sortino Ratio | 1.19 | ||
| Volatility | 16.25 | ||
| 14-Day RSI | 68.55 | ||
| 14-Day ATR ($) | 1.63849 | ||
| 20-Day SMA ($) | 111.529515 |
Fundamental Data
| Name | Value | ||
|---|---|---|---|
| Market Cap (Mil $) | 358.596 | ||
| Shares Outstanding (Mil) | 3.1 | ||
| PE Ratio | 21.07 | ||
| PE Ratio (10y Range) | 16.9 - 80.71 | ||
| PE Ratio (10y Median) | 20.1 | ||
| PB Ratio | 2.98 | ||
| PB Ratio (10y Range) | 2.52 - 3.93 | ||
| PB Ratio (10y Median) | 3.09 |
Dividend Data
| Name | Value | ||
|---|---|---|---|
| Dividends per Share (TTM) ($) | 1.065 | ||
| Dividend Yield % | 0.92 | ||
| Dividend Yield % (10y Range) | 0.54 - 1.4 | ||
| Dividend Yield % (10y Median) | 0.93 | ||
| Next Dividend Payment Date | |||
| Dividend Frequency | Quarterly |
PJP Invesco Pharmaceuticals ETF Fundamental Charts
Historical TTM Price-to-Earnings for PJP Invesco Pharmaceuticals ETF
Historical TTM Price-to-Earnings without NRI for PJP Invesco Pharmaceuticals ETF
Historical Price-to-Book Ratio for PJP Invesco Pharmaceuticals ETF
Historical Dividend Yields for PJP Invesco Pharmaceuticals ETF
Invesco Pharmaceuticals ETF Technical Indicators
Moving Average
Momentum
Gurus Latest Trades with ARCA:PJP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ARCA:PJP is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Invesco Pharmaceuticals ETF Top Holdings of 2026-01-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GILD | Gilead Sciences Inc | 161,829 | 22,971.6 | +43.04% | 5.720 | +1.72% | 0.010 | -9.84% | +2.14% | 153,756.0 | Drug Manufacturers | |
JNJ | Johnson & Johnson | 98,323 | 22,343.9 | +33.67% | 5.560 | +1.40% | 0.000 | +2.65% | +19.64% | 589,479.3 | Drug Manufacturers | |
MRK | Merck & Co Inc | 201,832 | 22,256.0 | +32.13% | 5.540 | +1.35% | 0.010 | +5.85% | +20.93% | 309,839.5 | Drug Manufacturers | |
PFE | Pfizer Inc | 803,654 | 21,248.6 | +54.26% | 5.290 | +1.86% | 0.010 | -11.80% | -1.75% | 134,905.8 | Drug Manufacturers | |
AMGN | Amgen Inc | 60,651 | 20,735.4 | +35.29% | 5.160 | +1.35% | 0.010 | +0.44% | +9.36% | 190,419.9 | Drug Manufacturers | |
ABBV | AbbVie Inc | 88,295 | 19,690.7 | +41.71% | 4.900 | +1.44% | 0.000 | +18.33% | +8.16% | 429,578.0 | Drug Manufacturers | |
LLY | Eli Lilly and Co | 18,973 | 19,677.8 | +7.57% | 4.900 | +0.34% | 0.000 | +23.28% | +5.29% | 1,005,607.9 | Drug Manufacturers | |
ABT | Abbott Laboratories | 159,338 | 17,415.6 | +61.51% | 4.340 | +1.65% | 0.010 | -10.50% | -24.73% | 162,406.7 | Medical Devices & Instruments | |
LQDA | Liquidia Corp | 375,819 | 15,931.0 | New Holding | 3.970 | +3.97% | 0.430 | +110.08% | +122.99% | 6,839.5 | Drug Manufacturers | |
VTRS | Viatris Inc | 1,061,979 | 13,901.3 | +56.12% | 3.460 | +1.24% | 0.090 | +19.91% | +31.14% | 18,714.4 | Drug Manufacturers |
Invesco Pharmaceuticals ETF's Historical Top Holdings Breakdowns
Invesco Pharmaceuticals ETF's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
LQDA | Liquidia Corp | 2026-01-31 | New Buy New Buy | +3.97% | 25.22 ($33.58) 43.06 | $76.91 | 129.04% | New holding | 375,819 | 375,819 | |
| AVDL Unlock Delisted | Avadel Pharmaceuticals PLC | 2026-01-31 | Sold Out Sold Out | -3.25% | 18.69 ($21.3) 23.56 | $21.64 | 1.60% | Sold Out | 0 | -476,856 | |
PCRX | Pacira BioSciences Inc | 2026-01-31 | Sold Out Sold Out | -2.10% | 19.16 ($23.6) 26.68 | $24.34 | 3.11% | Sold Out | 0 | -272,462 | |
PRGO | Perrigo Co PLC | 2026-01-31 | Add Add | +2.07% | 12.26 ($14.13) 20.53 | $9.68 | -31.49% | Add 196.2% | 883,888 | 585,476 | |
PFE | Pfizer Inc | 2026-01-31 | Add Add | +1.86% | 24.3 ($25.39) 26.5 | $23.67 | -6.77% | Add 54.26% | 803,654 | 282,692 | |
GILD | Gilead Sciences Inc | 2026-01-31 | Add Add | +1.72% | 118.15 ($124.95) 141.95 | $123.84 | -0.89% | Add 43.04% | 161,829 | 48,693 | |
ABT | Abbott Laboratories | 2026-01-31 | Add Add | +1.65% | 106.05 ($123.66) 130.59 | $93.24 | -24.60% | Add 61.51% | 159,338 | 60,680 | |
ABBV | AbbVie Inc | 2026-01-31 | Add Add | +1.44% | 211.96 ($224.77) 236.28 | $243.14 | 8.17% | Add 41.71% | 88,295 | 25,988 | |
PBH | Prestige Consumer Healthcare Inc | 2026-01-31 | Add Add | +1.42% | 57.47 ($61.9) 67.73 | $47.18 | -23.78% | Add 83.15% | 195,296 | 88,666 | |
JNJ | Johnson & Johnson | 2026-01-31 | Add Add | +1.40% | 186 ($206.6) 227.72 | $244.88 | 18.53% | Add 33.67% | 98,323 | 24,764 |
Invesco Pharmaceuticals ETF Total Holding History ($B)
Invesco Pharmaceuticals ETF's Asset Allocation
Invesco Pharmaceuticals ETF Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
Invesco Pharmaceuticals ETF's Hypothetical Growth since 2026-01-31
Invesco Pharmaceuticals ETF's Yearly Returns
This information is only displayed for Gurus who publicly disclose audited performance records; most hedge funds and private investment firms do not publish such data or only provide limited historical performance information.
| Year | Portfolio % | % | Excess Gain % |
|---|
Invesco Pharmaceuticals ETF's Holdings Heat Map
Size field: